The Y-mAbs Therapeutics brand, founded in 2014 (United States), from 2214 competing brands. Y-mAbs Therapeutics is owned by Y-mAbs Therapeutics, Inc, listed on the stock exchange of New York The sector of Y-mAbs Therapeutics is Biotechnology.

Y-mAbs Therapeutics is a brand of Y-mAbs Therapeutics, Inc (YMAB) Share price

Date created : 2014 Business sector Biotechnology

Share price and profitability of the share Y-mAbs Therapeutics, Inc (Y-mAbs Therapeutics)

Buy Y-mAbs Therapeutics, Inc share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 14.94

Portfolio valuation
Y-mAbs Therapeutics, Inc (Y-mAbs Therapeutics) over 5 years* USD 9.70

Stock market history Y-mAbs Therapeutics, Inc (Y-mAbs Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Y-mAbs Therapeutics, Inc

See more brands of Y-mAbs Therapeutics, Inc

Rival brands
Y-mAbs Therapeutics

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS